InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,307.88
(
0.48%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.63
(
0.25%
)
Bitcoin
61,481.60
(
-0.21%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 68
Posts 4505
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: dewophile post# 222184

Monday, 11/12/2018 4:35:48 PM

Monday, November 12, 2018 4:35:48 PM

Post# of 252412
>> Personally my money is on TKI and ADC since I think both hold promise in combination with PD-1s which may not be fully appreciated by the market


I agree with that completely. In short to intermediate term, combination with proven drugs and mechanism is the way to go which is why I say MRK opportunistic. Roche have a lot more than just IL-2 variant alone. They investigated then abandoned several popular IO targets quickly that proven right later.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up